Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
5.08
-0.04 (-0.78%)
At close: Mar 6, 2026, 4:00 PM EST
5.10
+0.02 (0.39%)
After-hours: Mar 6, 2026, 7:59 PM EST
Teladoc Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 2,530 | 2,570 | 2,602 | 2,407 | 2,033 | Upgrade
|
| Revenue Growth (YoY) | -1.54% | -1.26% | 8.13% | 18.41% | 85.81% | Upgrade
|
| Cost of Revenue | 771.59 | 751.27 | 760.03 | 743.99 | 650.26 | Upgrade
|
| Gross Profit | 1,758 | 1,818 | 1,842 | 1,663 | 1,382 | Upgrade
|
| Selling, General & Admin | 1,280 | 1,346 | 1,367 | 1,301 | 1,105 | Upgrade
|
| Research & Development | 277.92 | 307.27 | 348.52 | 333.63 | 311.88 | Upgrade
|
| Amortization of Goodwill & Intangibles | 350.76 | 363.37 | 325.93 | 234.72 | 195.3 | Upgrade
|
| Operating Expenses | 1,922 | 2,027 | 2,053 | 1,880 | 1,621 | Upgrade
|
| Operating Income | -163.4 | -208.79 | -210.5 | -217.47 | -238.99 | Upgrade
|
| Interest Expense | -19.71 | -23.8 | -22.28 | -21.94 | -81.14 | Upgrade
|
| Interest & Investment Income | 36.77 | 57.07 | 46.78 | 12.67 | 0.78 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | -0.81 | Upgrade
|
| Other Non Operating Income (Expenses) | 10.37 | -6.04 | 4.45 | -0.86 | - | Upgrade
|
| EBT Excluding Unusual Items | -135.97 | -181.56 | -181.56 | -227.6 | -320.17 | Upgrade
|
| Merger & Restructuring Charges | -27.8 | -22.1 | -38.05 | -23.04 | -26.64 | Upgrade
|
| Impairment of Goodwill | -71.76 | -790 | - | -13,403 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 5.9 | Upgrade
|
| Asset Writedown | - | - | - | -9.9 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -43.75 | Upgrade
|
| Pretax Income | -235.53 | -993.65 | -219.61 | -13,663 | -384.66 | Upgrade
|
| Income Tax Expense | -35.21 | 7.59 | 0.76 | -3.81 | 44.14 | Upgrade
|
| Net Income | -200.32 | -1,001 | -220.37 | -13,660 | -428.79 | Upgrade
|
| Net Income to Common | -200.32 | -1,001 | -220.37 | -13,660 | -428.79 | Upgrade
|
| Shares Outstanding (Basic) | 176 | 171 | 165 | 161 | 157 | Upgrade
|
| Shares Outstanding (Diluted) | 176 | 171 | 165 | 161 | 157 | Upgrade
|
| Shares Change (YoY) | 3.32% | 3.64% | 1.93% | 2.88% | 73.40% | Upgrade
|
| EPS (Basic) | -1.14 | -5.87 | -1.34 | -84.60 | -2.73 | Upgrade
|
| EPS (Diluted) | -1.14 | -5.87 | -1.34 | -84.60 | -2.73 | Upgrade
|
| Free Cash Flow | 285.46 | 282.89 | 338.56 | 172.81 | 185.46 | Upgrade
|
| Free Cash Flow Per Share | 1.62 | 1.66 | 2.06 | 1.07 | 1.18 | Upgrade
|
| Gross Margin | 69.50% | 70.76% | 70.80% | 69.09% | 68.01% | Upgrade
|
| Operating Margin | -6.46% | -8.13% | -8.09% | -9.04% | -11.76% | Upgrade
|
| Profit Margin | -7.92% | -38.96% | -8.47% | -567.53% | -21.09% | Upgrade
|
| Free Cash Flow Margin | 11.28% | 11.01% | 13.01% | 7.18% | 9.12% | Upgrade
|
| EBITDA | 33.06 | 31.72 | 43.61 | -7.54 | -31.42 | Upgrade
|
| EBITDA Margin | 1.31% | 1.23% | 1.68% | -0.31% | -1.55% | Upgrade
|
| D&A For EBITDA | 196.46 | 240.51 | 254.11 | 209.93 | 207.57 | Upgrade
|
| EBIT | -163.4 | -208.79 | -210.5 | -217.47 | -238.99 | Upgrade
|
| EBIT Margin | -6.46% | -8.13% | -8.09% | -9.04% | -11.76% | Upgrade
|
| Advertising Expenses | 648.48 | 693.21 | 673.55 | 609.45 | 397.77 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.